(Pathology) inflammation of the liver, characterized by fever, jaundice, and weakness. Seehepatitis A,hepatitis B,hepatitis C Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014 ...
TillmannDivision of GastroenterologyHans L.Division of GastroenterologyJournal of Infectious DiseasesTillmann HL, Hepatitis C: Hepatitis C virus infection: when is a cure not a cure? J Infect Dis 2014; 209:6-8
Intra-hepatic splenosis as an unexpected cause of a focal liver lesion in a patient with hepatitis C and liver cirrhosis: a case report Introduction Splenosis is the heterotopic autotransplantation of splenic tissue, mostly found after splenic trauma or surgery in the abdominal, pelvic or t... ...
In the 1970s, an unknown virus was suspected for documented cases of transfusion-associated hepatitis, a phenomenon called non-A, non-B hepatitis. In 1989, the infectious transmissible agent was identified and named hepatitis C virus (HCV) and, soon enou
Hepatology CommunicationsKim NJ, Magee C, Cummings C, Park H, Khalili M. Liver dis- ease monitoring practices after hepatitis C cure in the underserved population. Hepatol Commun. 2018;2:1274-1283. https://doi. org/10.1002/hep4.1246....
As mentioned above, the genome ofhepatitis C virusencodes a large protein called polyprotein. Theamino acidsequence of this protein is shown below and can be found in GenBank ADD13463.1. aProtease inhibitors used as drugs against anti-hepatitis C virus ...
IFITM1 is a tight junction protein that inhibits hepatitis C virus entry†‡ Type 1 interferon (IFN) continues to be the foundation for the current standard of care combination therapy for chronic hepatitis C virus (HCV) infection, ... Courtney,Wilkins,Jessica,... - 《Hepatology》 被引量...
High Hepatitis C cure rates among black and non-black HIV-infected adults in an urban center.Background Hepatitis C virus (HCV) cure rates have been similar in patients with and without HIV co-infection; however, in the ION-4 study, black patients treated with ledipasvir/sofosbuvir were ...
"Maviret will cure more than 99 percent of New Zealanders with hepatitis C, regardless of the type or severity of liver disease and previous treatment," he said. This provides a unique opportunity to eliminate hepatitis C from New Zealand, and should save 2,500 lives and removes the need fo...
As a country that is heavily burdened by hepatitis C, China’s successful responses to this public health threat have significant implications for the achievement of the global elimination goal. Methods This article reviews China’s strategies for prevention, screening, diagnosis, access to direct-act...